Mechanistic Investigation into the Phase Separation Behavior of Soluplus in the Presence of Biorelevant Media
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Justus Johann Lange und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University College Cork, College Road, Cork County, T12 R229 Cork , Ireland. Hauptthemen laut MEDLINE: Polyvinyls, Polyethylene Glycols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
More than a decade since its introduction, the polymeric excipient Soluplus continues to receive considerable attention for its application in the development of amorphous solid dispersions (ASDs) and its utility as a solubilizer for drugs exhibiting solubility limited absorption. While it is well-recognized that Soluplus forms micelles, the impact of its lower critical solution temperature of approximately 40 °C remains an underexplored aspect. This study investigated the phase behavior of Soluplus in fasted-state simulated intestinal fluid (FaSSIF-V1). It was demonstrated that Soluplus forms a dispersed polymer-rich coacervate phase, which coexists with Soluplus micelles at 37 °C. This behavior was confirmed by cloud point measurements, visually discernible phases after centrifugation, as well as multi-angle dynamic light scattering (MADLS) measurements, and quantitative 1H-nuclear magnetic resonance (NMR) spectroscopy of Soluplus concentrations in the supernatant pre- and post-centrifugation. The practical relevance of these findings was contextualized by solvent shift experiments and dissolution testing of spray-dried ASD. The results demonstrated that the poorly water-soluble drug RO6897779 resided in a polymer-rich coacervate phase and was spun down during centrifugation, which resulted in an amorphous pellet exhibiting the characteristics of a viscous liquid. The entrapment of the drug within the polymer-rich phase was further analyzed by temperature- and time-dependent MADLS experiments. The findings of this study are of particular relevance for a mechanistic understanding, relevant to comprehending in vitro-in vivo relationships of Soluplus-based ASDs. Low sampled drug concentrations in FaSSIF-V1 at 37 °C may originate not only from limited drug release and precipitation but also from the formation of a drug-containing, polymer-rich Soluplus phase. Therefore, a liquid-liquid phase separation occurring from Soluplus-based formulations in a biorelevant medium can be excipient-driven, which is different from the common perception that phase separation in the solution state is triggered primarily by high drug concentrations exceeding their amorphous solubility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University College Cork, College Road, Cork County, T12 R229 Cork , Ireland.
- Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
- Fraunhofer Institute for Translational Medicine and Pharmacology, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
- Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
- Analytical & Biological Research Facility, University College Cork, College Road, T12 YN60 Cork, Ireland.
- Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Hofackerstrasse 30, CH-4132 Muttenz, Switzerland.
ORCID-Profile: Justus Johann Lange, Malte Bøgh Senniksen, Susanne Page, Patrick J O'Dwyer, Martin Kuentz, Brendan T Griffin
Förderung
- H2020 Marie Sklodowska-Curie Actions
Zitieren
APA
Lange, J. J., Senniksen, M. B., Wyttenbach, N., Page, S., Bateman, L. M., O'Dwyer, P. J., Saal, W., Kuentz, M., & Griffin, B. T. (2025). Mechanistic Investigation into the Phase Separation Behavior of Soluplus in the Presence of Biorelevant Media. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01140
Vancouver
Lange JJ, Senniksen MB, Wyttenbach N, Page S, Bateman LM, O'Dwyer PJ, et al. Mechanistic Investigation into the Phase Separation Behavior of Soluplus in the Presence of Biorelevant Media. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01140
BibTeX
@article{Lange2025,
author = {Lange, Justus Johann and Senniksen, Malte Bøgh and Wyttenbach, Nicole and Page, Susanne and Bateman, Lorraine M and O'Dwyer, Patrick J and Saal, Wiebke and Kuentz, Martin and Griffin, Brendan T},
title = {Mechanistic Investigation into the Phase Separation Behavior of Soluplus in the Presence of Biorelevant Media},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01140}
}
EUVIMED